Evidence map›Paper›PMID 24378231›Full record

ArticleEmerging infectious diseases2014

Multisite validation of cryptococcal antigen lateral flow assay and quantification by laser thermal contrast.

David R Boulware, Melissa A Rolfes, Radha Rajasingham, Maximilian von Hohenberg, Zhenpeng Qin, Kabanda Taseera, Charlotte Schutz, Richard Kwizera, Elissa K Butler, Graeme Meintjes and 3 more

Registry-linked trialOpen access · diamondAbstract read
In one paragraph

Article in Emerging infectious diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01075152 (Trial for the Optimal Timing of HIV Therapy After Cryptococcal Meningitis), which is not on this map. Cited by 174 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
174citing papers in PubMed, 6 pooled it
12.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01075152 phase4completednot on this map

Trial for the Optimal Timing of HIV Therapy After Cryptococcal Meningitis

TypeinterventionalSponsorUniversity of MinnesotaRan2010 to 2013Enrolled177ConditionsCryptococcal Meningitis, HIV Infections, AIDSArmsefavirenz, nucleoside
3 · Its place in the literature

Who cites it

174 citing papers in PubMed, 6 syntheses or guidelines pooled it, 315 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Treatment for HIV-associated cryptococcal meningitis.The Cochrane database of systematic reviews · 2018
    Pooled it
  6. Pooled it
  7. Trial
  8. Oral Lipid Nanocrystal Amphotericin B for Cryptococcal Meningitis: A Randomized Clinical Trial.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Trial
  9. Trial
  10. Article
  11. Article
  12. Review
  13. False-Positive IMMYJournal of fungi (Basel, Switzerland) · 2026
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

114 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 3 countries.

David R Boulware
Melissa A Rolfes
Radha Rajasingham
Maximilian von Hohenberg
Zhenpeng Qin
Kabanda Taseera
Charlotte Schutz
Richard Kwizera
Elissa K Butler
Graeme Meintjes
Conrad Muzoora
John C Bischof
David B Meya
Twin Cities Orthopedics · USUniversity of Minnesota · USMbarara University of Science and Technology · UGUniversity of Cape Town · ZAMakerere University · UG

Funding

University of Minnesota Clinical and Translational Science Institute (UMN CTSI)UL1TR000114 · NCATS · UNIVERSITY OF MINNESOTA · PI BLAZAR, BRUCE R · 2012 to 2015
$35.0M
Trial for the Optimal Timing of HIV Therapy after Cryptococcal MeningitisU01AI089244 · NIAID · UNIVERSITY OF MINNESOTA · PI BOULWARE, DAVID R · 2010 to 2014
$7.6M
South Africa Tuberculosis/AIDS TrainingU2RTW007373 · FIC · UNIV OF NORTH CAROLINA CHAPEL HILL · PI VAN DER HORST, CHARLES MICHAEL · 2007 to 2012
$1.4M
Immune Reconstitution Syndrome in HIV infected Persons in Resource-Limited AreasK23AI073192 · NIAID · UNIVERSITY OF MINNESOTA · PI BOULWARE, DAVID R · 2009 to 2012
$530k
Impact of HIV and HIV therapy on the Etiology and Outcome of Meningitis in UgandaR21NS065713 · NINDS · UNIVERSITY OF MINNESOTA · PI BOHJANEN, PAUL R, BOULWARE, DAVID R · 2010 to 2011
$276k
FIC NIH HHS U2R TW007373NCATS NIH HHS UL1 TR000114NIAID NIH HHS K23 AI073192NIAID NIH HHS K23AI073192NIAID NIH HHS U01 AI089244NIAID NIH HHS U01AI089244NINDS NIH HHS R21 NS065713NINDS NIH HHS R21NS065713PHS HHS U2RTW007373-04
6 · The paper itself

Abstract

Cryptococcal meningitis is common in sub-Saharan Africa. Given the need for data for a rapid, point-of-care cryptococcal antigen (CRAG) lateral flow immunochromatographic assay (LFA), we assessed diagnostic performance of cerebrospinal fluid (CSF) culture, CRAG latex agglutination, India ink microscopy, and CRAG LFA for 832 HIV-infected persons with suspected meningitis during 2006-2009 (n = 299) in Uganda and during 2010-2012 (n = 533) in Uganda and South Africa. CRAG LFA had the best performance (sensitivity 99.3%, specificity 99.1%). Culture sensitivity was dependent on CSF volume (82.4% for 10 μL, 94.2% for 100 μL). CRAG latex agglutination test sensitivity (97.0%-97.8%) and specificity (85.9%-100%) varied between manufacturers. India ink microscopy was 86% sensitive. Laser thermal contrast had 92% accuracy (R = 0.91, p<0.001) in quantifying CRAG titers from 1 LFA strip to within <1.5 dilutions of actual CRAG titers. CRAG LFA is a major advance for meningitis diagnostics in resource-limited settings.

Indexed as

AIDS-Related Opportunistic InfectionsAntigens, FungalChromatography, AffinityCryptococcusHumansMeningitis, CryptococcalPoint-of-Care SystemsReproducibility of ResultsSensitivity and SpecificityAntigens, Fungalcerebrospinal fluidcryptococcal antigencryptococcal antigen latex agglutinationcryptococcal meningitisCryptococcus spp.culturediagnostic techniquesfungiHIVIndia ink microscopylaser thermal contrast measurementlateral flow immunochromatographic assaypoint-of-care systemssensitivitySouth AfricaspecificityUgandavalidation studies

Identifiers

PMID24378231
PMCPMC3884728
OpenAlexW1976256249

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.